In this conversation, Greg Duncan, CEO of Dogwood Therapeutics, discusses his extensive career in the biotech industry, the formation of Dogwood Therapeutics, and the innovative non-opioid pain management solution, Halneuron. He elaborates on the clinical trials for Halneuron, its potential applications, and the company's focus on addressing pain and neuropathy associated with chemotherapy. Additionally, Duncan shares insights into other therapeutic avenues being explored by Dogwood, including treatments for fibromyalgia and long COVID, and emphasizes the importance of improving patient quality of life.Dogwood Therapeutics Website: https://www.dwtx.com/Nano Cap Podcast Website: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

Ver todos los episodios